Staar Surgical Co (NASDAQ:STAA) currently has a daily average trading volume of 734.01K but it saw 2441871 shares traded in last market. With a market cap of 786.45M USD, the company’s current market price of $15.96 came falling about -3.16 while comparing to the previous closing price of $16.48. In past 52 weeks, the stock remained buoying in the range of price level as high as $52.68 and as low as $13.50. In the recent trading on the day, stock has struck highest price mark of $15.55 while lowest mark touched by it was $16.6731.
Taking a look at 20-day trading activity of Staar Surgical Co (STAA) gives us an average price of $22.63, while its current price level is -69.70% below from 52-week high level whereas it is 18.22% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $23.78 while that of 200 days or SMA-200 reads an average of $33.50. A closer look into the stock’s movement over the week reveals that its volatility is standing at 9.15% during that period while stretching the period over a month that decreases to 5.36%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 20.86 which implies that the stock is in oversold territory.
Mizuho downgraded its recommendation for the stock as a “Neutral” from “Outperform” on February 12, 2025 while assigning a price target range of $45-$17.
Over the week, STAA’s stock price is moving -30.09% down while it is -26.28% when we observe its performance for the past one month. Year-to-date it is -34.29% down and over the past year, the stock is showing a downside performance of -49.07%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.59 while estimate for next year EPS is -0.89. In next quarter, company is expected to be making quarterly sales of $47.33M as analysts are expecting the sales for current fiscal year at $269.8M and seeing the company making $342M in sales next year. Moreover, analysts are in estimates of $44.29M for current-quarter revenue.
Currently, Staar Surgical Co’s total number of outstanding shares is 49.28M with 0.52% of that held by the insiders while 100.36% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -4.68% and return on equity (ROE) at -5.16%. It has a 177.33 of forward P/E ratio. Stock’s beta reads 0.64. Stock has a price to book (P/B) ratio of 1.84 while price to sale or P/S ratio amounts to 2.51. Its return on asset (ROA) is -4.05% on average.
